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SUMMARY Right and left ventricular (RV and LV) volumes were determined in 19 patients with absent pulmonary valve syndrome using Simpson's rule and area-length methods. The volume of the proximal right pulmonary artery (RPAV) was calculated at maximal and minimal size using the area-length method. Patient groups included four newborns who responded to medical management (group 1A), seven critically ill newborns who died (group iB), four infants ages 1-10 months (group 2) and four children ages 2-8 years (group 3). The RVend-diastolic volume in groups 1B and 2 was significantly greater than that in groups 1A and 3. The RV ejection fraction in groups lB and 2 was significantly less than that in normal patients and groups 1A and 3. Maximal RPAV correlated well with RV stroke volume and end-diastolic volume. The maximal RPAV in group 1B was significantly greater than that in groups 1A and 3. Pulmonary arterial compliance was greater than normal in all groups, and the compliance in group 1B was more than two times that in the other groups. We conclude that the increased right pulmonary artery compliance and pulmonary regurgitation in patients with absent pulmonary valve contribute to bronchial obstruction and right-heart failure and are the causes of the high morbidity and mortality in these patients. The management should be directed to the alleviation of bronchial obstruction and right-heart failure. THE ABSENT pulmonary valve syndrome (APVS) usually consists of an absent pulmonary valve, a ventricular septal defect, mild-to-severe right ventricular (RV) outflow obstruction, and aneurysmal dilatation of the pulmonary arteries. The obstruction is almost always located at the pulmonary valve ring, and sometimes at the infundibulum as well. 1-3 This combination of the lesions is better known as tetralogy of Fallot with absent pulmonary valve.
Calder et al.4 reviewed 233 cases with APVS and reported that many infants die early from severe respiratory distress and intractable cardiac failure. Bronchial compression by distended pulmonary arteries is a particular problem in patients with APVS in early infancy. 2 5,6 However, the relationship between RV function and the aneurysmal dilatation of the pulmonary arteries is not known. Furthermore, it is not clear how often RV and left ventricular (LV) function influence the morbidity and mortality of these patients. In this study we describe the characteristics of RV and LV performance in newborns, infants and children with APVS. determine the relationship between RV volume variables and the size of the right pulmonary artery (RPA) and assess the effect of RV, LV and RPA volume variables on the morbidity and mortality of patients with APVS.
Methods

Patients
Data were obtained in 19 patients who had APVS confirmed by diagnostic cardiac catheterization. Patients were separated into three groups according to their age at the time of the cardiac catheterization. Group 1 included 11 newborns, ages 1-6 days. This group was subdivided into group IA, which included four patients who required a short hospital stay (less than 2 weeks) and responded to medical management. Their pulmonary atelectasis was small; group IB included seven patients who had pulmonary atelectasis involving more than one lobe and right-heart failure. These patients required an extensive hospital stay (more than one-half of their life by the time of their death), and all died.
Group 2 included four infants, ages 1-10 months. Two of the four required frequent hospital admissions and were operated on. Group 3 included four children, ages 2-8 years, two of whom had elective surgery.
The hemodynamic and volume data in the three groups were compared with normal values in patients of comparable ages. These included seven newborns, 10 infants and 10 children who had a normal heart, mild valvular pulmonary stenosis (RV pressure < 45 mm Hg), a small ventricular septal defect (Qp/Qs < 1.3), pulmonary disease with normal pulmonary arterial pressure, peripheral pulmonary stenosis, vascular ring, bicuspid aortic valve with no significant gradient and mediastinal mass.
Data Acquisition
Data were obtained during diagnostic cardiac catheterization. Infants younger than 3 months of age were not premedicated and those 3-12 months old were given morphine (0. 1 mg/kg) only. All other patients were premedicated with meperidine, 1 mg/kg, promethazine, 0.5 mg/kg, and chlorpromazine, 0.5 mg/ kg. Before the first cineangiogram was taken, the RV, LV and pulmonary arterial pressures were recorded using NIH catheters and a Statham P23-AA transducer. At the same time, the Qp/Qs ratio was quantified by the Fick method. Biplane cineangiography (anteroposterior and lateral views) was performed at 60 frames/sec after injecting meglumine diatrizoate (Renografin-76), 1.0-1.25 ml/kg, into the right and left ventricles, pulmonary artery and left atrium in all but one patient, who had only single-plane cineangiography (anteroposterior view). Only normal sinus beats were analyzed. RV and LV volumes were calculated at end-diastole and end-systole using Simpson's rule method7 and the area-length method,8' 9 respectively. All values were corrected by separate regression equations.7 l The following variables were calculated from end-diastolic and end-systolic volumes (EDV and ESV:
Stroke volume (SV) EDV ESV Ejection fraction (EF) = SV/EDV Systolic index = SV x heart rate (HR) body surface area RVEDV and LVEDV were expressed as a percentage of normal predicted values." Proximal RPA was defined as a portion from the right boundary of the main pulmonary artery to the appearance of the first branch of the RPA (fig. 1 ). The volume of the RPA (RPAV) was calculated by area-length method assuming an ellipsoid of revolution: (1)
Since the radius was not measured, we derived this radius from the area and longest length (LL) using the equation:
It should also be noted that LL
ri
After substituting equations 2 and 3 in 1, obtained V 0.8488 x At A1 LLI (2) (3) we (4) where Af = planimetered area on frontal view, A, planimetered area on lateral view, LL, = maximal length on lateral view. The maximal and minimal volumes were obtained from the average values of two consecutive beats, respectively. The change in RPAV (ARPAV) was the difference between maximal and minimal values. The following variables were also calculated: (1) maximal RPAV index -max RPAV/ 
Statistics
The t test and one-way analysis of variance were used to test for difference of the mean values between two groups and three groups, respectively. A p value < 0.05 was considered significant. Linear regression analyses were performed using the least-squares method.
Results
Anatomic Features
The patients' age, body surface area and hemodynamic data are shown in table 1. Cineangiography demonstrated that all patients had a ventricular septal defect and aneurysmal dilatation of the RPA or left pulmonary artery (LPA) or both. The relative dilata- tion of the RPA and LPA was similar in 13 patients. The RPA was dominant in four patients and the LPA was dominant in two. There was a peak systolic gradient through the pulmonary valve ring in all but two patients (nos. 5 and 13) . Only four patients, 3, 6, 12 and 17, had mild-to-moderate infundibular stenosis. Patient 6 had stenosis at the bifurcation of the main pulmonary artery, patients 10 and 19 had RPA branch stenosis and patient 2 had bilateral branch stenosis. Patients 9 and 14 had an atrial septal defect. The LPA originated from the ascending aorta in patient 9 and from a very tortuous collateral vessel of the left carotid artery in patient 16. Ten patients underwent pulmonary arteriography and demonstrated moderate-to-severe pulmonary regurgitation.
Hemodynamic Data
The HR during RV cineangiography was within 5% of the rate during LV cineangiography. Peak systolic RV pressure was significantly higher (p < 0.001) than normal in all groups. Systolic pulmonary arterial pressure in newborns was higher than that in children. This variable, however, was not significantly different from normal. Aortic oxygen saturation in group lB averaged 80 + 10% and was lower than normal but the values in other groups were greater than 80% and were not significantly different from normal. The Qp/Qs ratio could be calculated in 12 patients with pulmonary venous samples. Only two of four patients in group 1B had a dominant right-to-left shunt at the atrial or ventricular level. All other patients had dominant left-toright shunts.
Ventricular Volume Variables (table 2) The normal RV and LV volume variables for newborns and infants were similar, but were significantly different from values in children (group 3). The normal RV and LV volume variables reported in this study were similar to those reported previously.7 ' 9 RVEDVs in groups IA, lB and 2 were significantly greater than normal (fig. 2 ). The RVEDV in group B was not significantly different from that in group 2 and the values in these two groups were significantly greater than in group lA. This variable in group 3 was significantly less than that in groups lB and 2 ( fig. 2 ).
RVEF was significantly less than normal in groups IA, lB and 2, but was normal in group 3. In group lB, it was significantly less than that in groups IA and 3 (table 2). The RV systolic index in groups IA, lB and 2 was significantly greater than normal, and there was no significant difference between these three groups. RV systolic index was normal in group 3. LVEDV was significantly less than normal in group LA, but was normal in all other groups. There was no difference between groups. LVEF was significantly less than normal in groups IA and lB and was normal in groups 2 and 3. LV systolic index was significantly less than normal in groups 1A, LB and 2, but was normal in group 3. There was no significant difference between groups. (table 3) The maximal RPAV index was significantly greater than normal in all groups. The relative increase (percentage of normal values) in group lB was significantly greater than in groups lA, 2 and 3. The maximal RPAV index in group 3 was significantly less than that in other groups.
RPAV Variables
The ratios of maximal RPAV/RVEDV, maximal RPAV/RVSV, and ARPAV/RVSV in all groups were significantly (p < 0.001) greater than normal, and there was no difference between groups. The relationship between RPAV variables, and RVEDV and RVSV are shown in figures 3 and 4. Maximal RPAV correlated well with RVEDV and RVSV in the three groups.
Pulmonary Arterial Compliance
Pulmonary arterial compliance in normal children was approximately nine times that in the normal newborn. It was significantly greater than normal in all patients with APVS. Pulmonary arterial compliance in group LB was significantly greater than that in groups LA, 2 and 3. Compliance in group 2 was significantly greater than that in group 1A.
Correlation Between the Clinical Course and Volume Variables
Patients in groups LA and 3 had mild symptoms and responded to medical management. Groups lB and 2 both included sick patients who did not respond to medical management. All patients in group LB died, and two infants included in group 2 required surgery. Two of these three infants had total correction, including placement of a valved external conduit (modified Hancock) under deep hypothermia, with excellent surgical results. The RVEDV in groups 1B and 2 was significantly greater than that in groups lA and 3. RVEF was also significantly depressed in groups LB and 2. However, these differences were not significant between the two groups. The RPAV index in group LB was significantly greater than that in groups 1A, 2 and 3. Furthermore, RPAC compliance in group lB was significantly greater than that in groups LA, 2 and 3.
Discussion
The purpose of this study was to determine ventricular volume variables and RPAV, and to correlate these findings with the patient's hemodynamics and clinical course. The RVEDV was increased in groups LA, LB and 2, but not in group 3. The maximal increase in the RVEDV was observed in groups lB and 2, and was associated with a significant decrease in RVEF. However, there was no significant difference in RV volume variables between group LB and group 2. There was no relationship between the LV volume variables and the clinical course. These data suggest a good correlation between RV volume variables and the clinical course of these patients.
Although we assume that the increase in RVEDV is caused by pulmonary regurgitation, the relationship between RPAV and RV volume variables has not been examined previously. The RPAV/RVEDV, RPAV/ RVSV and ARPAV/RVSV ratios were similar in all groups (table 3) . This finding indicates that the pulmonary arterial volume and RVEDV are closely related. The cause and effect of this relationship have not been determined.
The RPAV in sick newborns (group LB) was 17.7 times the normal values, and it was significantly greater than that in all other groups. RPAV in sick infants (group 2) was also greater than that in group 3 (asymptomatic children). Thus, the relative size of the RPA has a direct relationship to the clinical course and mortality in these patients. The large pulmonary artery obstructed the bronchus and caused respiratory distress in most of the critically ill patients.
The causes of the enlargement of the RPA should be considered. One possible explanation is the pulmonary arterial pressure. This is unlikely, since there was no correlation between the size of the RPA and pulmonary arterial pressure. Another possible explanation is the Abbreviations: Max RPAVI = maximum right pulmonary arterial volume index; RVEDV = right ventricular enddiastolic volume; RVSV = RV stroke volume; ARPAV = change of right pulmonary artery volume from systole to diastole; AP = change of pulmonary artery pressure from systole to diastole. systolic gradient across the pulmonary valve annulus. Again, there was no correlation between annulus gradient and pulmonary arterial volume. A third possibility is the large RVSV. Although the RPAV/RVSV ratio in the APVS groups was greater than normal, there was no significant difference between groups (table 3, fig. 3 ). This suggests that the large RVSV might be the result, and not the cause, of pulmonary 88 CIRCULATION _--ble age. The pulmonary arterial compliance was 23 times normal in the sick newborns and only nine times normal in newborns with a good clinical course. Thus, pulmonary arterial compliance is apparently the major determinant of the size of the RPA. This, in turn, may increase pulmonary arterial regurgitation, RVSV and RVEDV.
Previous pathologic studies indicated that the histology of the RPA was normal6, 11 or abnormal.'2' 13 A marked decrease of the elastic fibers in the media of the pulmonary artery has been observed.'2 In this study, we did not examine the histology of the pulmonary arterial wall and therefore could not correlate pulmonary arterial compliance and histology. However, according to the Laplace formula, the RPA wall tension in patients with APVS is great and a normal pulmonary arterial histology (with normal thickness) cannot withstand this high wall tension; that is, there is disproportion between pulmonary arterial wall force and histology.
In patients with APVS, the increase in RVEDV was associated with a significant decrease in RVEF (table 2, fig. 2 ). The RVEF in groups lB and 2 was significantly less than in group lA. An acute increase in muscle length (increased preload) will result in an increase in percent shortening and EF. This suggests that the increased RVEDV should cause an increase in RVEF. Two reasons, however, might explain the depression in RVEF. First, the increase in RVEDV is associated with an increase in RV diameter and RV wall stress (increased afterload). This could be more important than the increase in muscle length and could cause a depression in RVEF. Second, this increase in RV volume overload is chronic. The decreased RVEF in these patients is in agreement with previous observations in chronic LV volume overload in infants'4 and instrumented awake dog. 15 The present study is also in agreement with results of RV function of acute dog experiments after resection of the pulmonary valve. 16 The mechanisms for the depression in RV function could be the increased RV wall stress, and it might be caused by a decrease in coronary reserve. 17 The present study indicates that the primary problem in these patients is an increase in the pulmonary arterial compliance. This, in association with APVS, causes significant increases in the RPA or LPA size and increased RVEDV and a decreased RVEF. Both bronchial obstruction and RV dysfunction are responsible for the poor prognosis in the newborn with this clinical entity. Patients with the severe form of the disease usually die in the newborn period, while those with mild and moderate forms survive to older age and undergo elective surgery. Thus, one cannot compare the newborn population with children. The surgical results in the newborn have been poor; thus, Lakier et al.2 and Pinsky et al.5 recommended medical management in newborns. Although we agree with this approach, surgery must be considered in patients who do not respond to medical management. In infants, the respiratory and cardiac symptoms are less severe than in the newborn. In the present study, two infants had successful surgical repair at 1 and 3 months of age. A valve conduit was used in these two patients. They are asymptomatic and on no medication 3 and 4 years postoperatively. This suggests that insertion of a pulmonary valve improved the clinical course. This observation is in agreement with the data published by Ilbawi et al. '8 In the short term, the valve reduces RV size and systolic work as well as the size of the dilated pulmonary artery. It also improves forward RV output. These valves, however, might require anticoagulant therapy or replacement because of valve calcification. Litwin et al. 19 advocated the replacement of the dilated RPA with a woven tubular prosthetic graft. This procedure relieves bronchial obstruction and improves forward pulmonary flow, but the conduits usually calcify and must be replaced. Others20 21 use plication of the RPA, which reduces the size acutely and allows for future growth. Children are usually asymptomatic and surgery is scheduled electively. The ventricular defect is closed and RV outflow obstruction is removed. In addition, the RPA is resected to reduce the pulmonary arterial diameter. Although Pinsky et al. 5 indicated that the valve insertion should be reserved for those patients with pulmonary hypertension, others'" indicated that valve insertion improved the clinical course.
In conclusion, we recommend aggressive medical treatment of the pulmonary atelectasis and right heart failure in the sick newborn. If this approach fails, surgery should be attempted to reduce the size of the RPA and eliminate the hemodynamic problem (closure of the ventricular septal defect, relief of the RV outflow obstruction, and valve insertion in patients with pulmonary hypertension). In older infants and children, complete correction should include the closure of the ventricular septal defect, relief of RV outflow obstruction and prosthetic pulmonary valve in patients with pulmonary hypertension. In patients with normal pulmonary arterial pressure postoperatively, valve insertion might be avoided to eliminate the need for anticoagulant and later valve replacement.
